cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Chinook Therapeutics Inc
2 own
3 watching
Current Price
$0
$0.25
(1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,600.39M
52-Week High
52-Week High
27.44
52-Week Low
52-Week Low
15.08
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,600.39M
icon52-Week High27.44
icon52-Week Low15.08
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Chinook Therapeutics Inc do?
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company s lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.
Read More
How much money does Chinook Therapeutics Inc make?
News & Events about Chinook Therapeutics Inc.
Globe Newswire
17hours ago
NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against JinkoSolar Holding Co., Ltd. (NYSE: JKS), Integra LifeSciences Holdings Corp. (NASDAQ: IART), and Chinook Therapeutics, Inc. (NASDAQ...
PR Newswire
6hours ago
CHINOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Chinook To Contact Him Directly To Discuss Their Options CHINOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson...
Globe Newswire
2 months ago
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced presentations at the ISN World Congress of Nephrology 2023 from ...
Globe Newswire
3 months ago
SEATTLE, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the appointment of Andrew Oxtoby as chief commercial officer. We ...
Globe Newswire
7 months ago
BION-1301 Treatment Results in Rapid and Durable Reductions in IgA and Gd-IgA1 in Patients with IgA Nephropathy Following both IV and SC dosing, BION-1301 produced rapid and sustained reductions in IgA and Gd-IgA1, the pathogenic variant of IgA nephropathy BION-1301 Treatment Results in ...
Frequently Asked Questions
Frequently Asked Questions
What is Chinook Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Chinook Therapeutics Inc shares?
plus_minus_icon
How can I buy Chinook Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Chinook Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Chinook Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Chinook Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Chinook Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Chinook Therapeutics Inc?
plus_minus_icon
What percentage is Chinook Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Chinook Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.25
(1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
89bio Inc
89bio Inc
$20.41
$0.23 (1.17 %)
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
$27.31
$0.15 (0.55 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$21.80
$0.00 (0.00 %)
Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
$23.57
$0.11 (0.47 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
89bio Inc
89bio Inc
$20.41
$0.23 (1.17 %)
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
$27.31
$0.15 (0.55 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$21.80
$0.00 (0.00 %)
Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
$23.57
$0.11 (0.47 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00